Results 191 to 200 of about 4,194,617 (361)
FMLA Scope, Coverage, and Eligibility [PDF]
Workplace Flexibility 2010, Georgetown University Law Center
core +1 more source
Global policy scan of commercial combustible tobacco product retailing regulations by WHO region. [PDF]
Canty R, Gartner CE, Hoek J, Hefler M.
europepmc +1 more source
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
Host Country Regulation of Short-Term Medical Missions: Evidence from Three Countries. [PDF]
Calgua-Guerra E +9 more
europepmc +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Short Term Time Off Options for Federal Employees [PDF]
Workplace Flexibility 2010, Georgetown University Law Center
core +2 more sources
Technology and Labor Regulations [PDF]
Many low skilled jobs have been substituted away for machines in Europe, or eliminated, much more so than in the US, while technological progress at the “top”, i.e. at the high-tech sector, is faster in the US than in Europe. This paper suggests that the
Alberto Alesina, Joeph Zeira
core
Conformity Assessment of Medical Devices: An Overview from a Notified Body. [PDF]
Stange AF, Julian E.
europepmc +1 more source
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source

